Survival and Hemodynamic Effects of Parenteral Prostanoids in High-Altitude Group 1 Pulmonary Hypertension: A Retrospective Cohort Study.
Background In Latin America, the evidence regarding the use of prostanoids at high altitude in patients with Group 1 pulmonary hypertension (PH‐1) is limited. Therefore, it is essential to describe the clinical characteristics and outcomes associated with prostanoid treatment in this population. Methods This retrospective study involved patients with PH‐1. Hemodynamic and clinical variables were compared before the initiation of prostanoids and during clinical follow‐up. Overall survival was...